6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human fragile site FRA16B DNA excludes nucleosomes in the presence of distamycin.

      The Journal of Biological Chemistry

      Antiviral Agents, pharmacology, Base Sequence, Binding, Competitive, Chromosome Fragile Sites, Chromosome Fragility, Chromosomes, Human, Pair 16, DNA, metabolism, Distamycins, Dose-Response Relationship, Drug, HeLa Cells, Humans, Molecular Sequence Data, Nucleosomes, Plasmids, Trinucleotide Repeat Expansion

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human fragile sites are weak staining gaps in chromosomes generated by specific culture conditions. The short CGG repeating DNA derived from folate-sensitive fragile sites has been shown to exclude single nucleosomes. To test whether this nucleosome exclusion model provides a general molecular mechanism for the formation of fragile sites, a different class of fragile site, the 33-base pair AT-rich repeating DNAs derived from the rare distamycin-inducible site, FRA16B, was examined for its ability to assemble single nucleosomes and nucleosome arrays using in vitro nucleosome reconstitution methods. The FRA16B DNA fragments strongly exclude nucleosome assembly only in the presence of distamycin, and increasing the number of 33-bp repeats increases the effect of distamycin in the destabilization of the nucleosome formation, suggesting a common mechanism for the formation of fragile sites.

          Related collections

          Author and article information

          Journal
          11880377
          10.1074/jbc.M200901200

          Comments

          Comment on this article